The latest financial statement is for the year ending 2025-12-31.
| Cash Flow | 2025-12-31 |
|---|---|
| Net income | 50,302 |
| Net accretion of available-for-sale securities | 291 |
| Amortization of core deposit intangible | 576 |
| Provision for credit losses | 4,653 |
| Loan hedge fair value adjustments, including amortization | 140 |
| Change in net deferred loan origination fees | -1,337 |
| Mortgage loans originated for sale | 6,525 |
| Proceeds from sale of mortgage loans held for sale | 8,860 |
| Write down on consumer loans transferred to held for sale | 517 |
| Gain on sale of mortgage loans | 165 |
| Depreciation and amortization expense | 3,022 |
| Gain from boli death benefit | 25 |
| Increase in cash surrender values of boli | 3,268 |
| Deferred income tax expense (benefit) | 3,330 |
| Esop expense | 3,568 |
| Stock-based compensation | 2,910 |
| Accrued interest receivable | 1,144 |
| Prepaid expenses and other assets | -5,123 |
| Accrued expenses and other liabilities | -8,874 |
| Accrued retirement liabilities | -3,254 |
| Net cash provided by operating activities | 60,792 |
| Loan originations and purchases, net of repayments | 505,958 |
| Purchases of available-for-sale securities | 101,500 |
| Proceeds from sales of available-for-sale securities | 23,963 |
| Proceeds from maturities, calls and paydowns of available-for-sale securities | 67,475 |
| Recoveries of loans previously charged off | 2,264 |
| Net change in non-public investments | -2,649 |
| Acquisition, net of cash and cash equivalents acquired | 48,120 |
| Proceeds from boli death benefit | 128 |
| Proceeds from surrender (purchases) of boli policies | 48,764 |
| Purchases of banking premises and equipment | 3,417 |
| Net cash used in investing activities | -519,050 |
| Net change in deposits | 540,120 |
| Net change in mortgagors' escrow accounts | 4 |
| Repurchase of common shares under share repurchase plans | 77,125 |
| Dividends declared and paid | 5,575 |
| (decrease) increase in fhlb borrowings, net | 44,575 |
| Net cash provided by financing activities | 501,999 |
| Net change in cash and cash equivalents | 43,741 |
| Cash and cash equivalents at beginning of period | 363,855 |
| Cash and cash equivalents at end of period | 407,596 |
NB Bancorp, Inc. (NBBK)
NB Bancorp, Inc. (NBBK)